29.82MMarket Cap-893P/E (TTM)
3.6000High3.2000Low115.15KVolume3.2000Open3.1900Pre Close403.39KTurnover1.39%Turnover RatioLossP/E (Static)8.42MShares9.576052wk High-2.71P/B29.33MFloat Cap3.050052wk Low--Dividend TTM8.29MShs Float1304.4000Historical High--Div YieldTTM12.54%Amplitude3.0500Historical Low3.5030Avg Price1Lot Size
Dare Bioscience Stock Forum
Daré Bioscience Regains Compliance with Nasdaq Minimum Bid Price Rule
Benzinga
Phase 2b study demonstrated topical Sildenafil Cream, 3.6% improved outcomes among women with female sexual arousal disorder (FSAD), particularly in an exploratory subset of women with FSAD with or without concomitant decreased desire
There are currently no FDA-approved ...
As an Investor Catalyst Hub spoke, Daré gains access to potential funding and flexible contracting for faster award execution compared to traditional government contracts. Spok...
No comment yet